Report - A14-17 - Ruxolitinib - Nutzenbewertung gemäß §35a SGB V

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form